ALEMS — European Medical Solutions Cashflow Statement
0.000.00%
- €23.28m
- €36.95m
- €45.13m
- 48
- 37
- 31
- 27
Annual cashflow statement for European Medical Solutions, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -1.36 | -0.241 | -5.58 | -5.02 | 0.547 |
Depreciation | |||||
Non-Cash Items | 0.602 | — | 3.22 | 0.314 | 0.456 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.793 | -1.43 | 0.6 | -1.26 | -0.49 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -1.38 | 0.348 | 2.33 | -1.65 | 2.56 |
Capital Expenditures | — | -1.92 | -2.21 | -2.72 | -3.57 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.638 | 0.578 | 1.22 | 1.25 | 0.68 |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0.638 | -1.34 | -0.992 | -1.48 | -2.89 |
Financing Cash Flow Items | -0.002 | -0.521 | 0.121 | 0 | -0.616 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -0.059 | 2 | 0.471 | 3.48 | 0.718 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.798 | 1.01 | 1.8 | 0.362 | 0.383 |